<VariationArchive VariationID="2506580" VariationName="NM_000489.6(ATRX):c.399_400dup (p.Leu134fs)" VariationType="Duplication" Accession="VCV002506580" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-12-30" MostRecentSubmission="2023-12-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2671547" VariationID="2506580">
      <GeneList>
        <Gene Symbol="ATRX" FullName="ATRX chromatin remodeler" GeneID="546" HGNC_ID="HGNC:886" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="77504880" stop="77786216" display_start="77504880" display_stop="77786216" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="76760355" stop="77041718" display_start="76760355" display_stop="77041718" Strand="-" />
          </Location>
          <OMIM>300032</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATRX">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-31" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATRX">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000489.6(ATRX):c.399_400dup (p.Leu134fs)</Name>
      <CanonicalSPDI>NC_000023.11:77693907:GC:GCGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="77693907" stop="77693908" display_start="77693907" display_stop="77693908" variantLength="2" positionVCF="77693907" referenceAlleleVCF="A" alternateAlleleVCF="AGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="76949396" stop="76949397" display_start="76949396" display_stop="76949397" variantLength="2" positionVCF="76949396" referenceAlleleVCF="A" alternateAlleleVCF="AGC" />
      </Location>
      <ProteinChange>L134fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.76949397_76949398dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.76949397_76949398dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.77693908_77693909dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.77693908_77693909dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008838.3" sequenceAccession="NG_008838" sequenceVersion="3" change="g.97361_97362dup">
            <Expression>NG_008838.3:g.97361_97362dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000489.6" sequenceAccession="NM_000489" sequenceVersion="6" change="c.399_400dup" MANESelect="true">
            <Expression>NM_000489.6:c.399_400dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000480.3" sequenceAccession="NP_000480" sequenceVersion="3" change="p.Leu134fs">
            <Expression>NP_000480.3:p.Leu134fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_138270.5" sequenceAccession="NM_138270" sequenceVersion="5" change="c.370+2668_370+2669dup">
            <Expression>NM_138270.5:c.370+2668_370+2669dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1153" sequenceAccession="LRG_1153">
            <Expression>LRG_1153:g.97361_97362dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1153t1" sequenceAccession="LRG_1153t1">
            <Expression>LRG_1153t1:c.399_400dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1153p1" sequenceAccession="LRG_1153p1" change="p.Leu134Argfs">
            <Expression>LRG_1153p1:p.Leu134Argfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000489.6(ATRX):c.399_400dup (p.Leu134fs) AND Intellectual disability-hypotonic facies syndrome, X-linked, 1" Accession="RCV003459814" Version="2">
        <ClassifiedConditionList TraitSetID="6540">
          <ClassifiedCondition DB="MedGen" ID="C4759781">Intellectual disability-hypotonic facies syndrome, X-linked, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-12-30" MostRecentSubmission="2023-12-30">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6540" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5503" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">XLMR-HYPOTONIC FACIES SYNDROME</ElementValue>
                <XRef Type="MIM" ID="309580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HOLMES-GANG SYNDROME</ElementValue>
                <XRef Type="MIM" ID="309580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation-hypotonic facies syndrome X-linked, 1</ElementValue>
                <XRef ID="Mental+retardation-hypotonic+facies+syndrome+X-linked%2C+1/4666" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Smith Fineman Myers syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHUDLEY-LOWRY SYNDROME</ElementValue>
                <XRef Type="MIM" ID="309580" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chudley syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chudley-Lowry-Hoar syndrome</ElementValue>
                <XRef ID="MONDO:0019775" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carpenter-Waziri syndrome</ElementValue>
                <XRef ID="MONDO:0019777" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked intellectual disability-hypotonic face syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability-hypotonic facies syndrome, X-linked, 1</ElementValue>
                <XRef ID="MONDO:0010663" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRXHF1</ElementValue>
                <XRef Type="MIM" ID="309580" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is characterized by distinctive craniofacial features, genital anomalies, hypotonia, and mild-to-profound developmental delay / intellectual disability (DD/ID). Craniofacial abnormalities include small head circumference, telecanthus or widely spaced eyes, short triangular nose, tented upper lip, and thick or everted lower lip with coarsening of the facial features over time. While all affected individuals have a normal 46,XY karyotype, genital anomalies comprise a range from hypospadias and undescended testicles, to severe hypospadias and ambiguous genitalia, to normal-appearing female external genitalia. Alpha-thalassemia, observed in about 75% of affected individuals, is mild and typically does not require treatment. Osteosarcoma has been reported in a few males with germline pathogenic variants.</Attribute>
                <XRef ID="NBK1449" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3521" />
                <XRef ID="3521" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301622</ID>
                <ID Source="BookShelf">NBK1449</ID>
              </Citation>
              <XRef ID="73220" DB="Orphanet" />
              <XRef ID="93970" DB="Orphanet" />
              <XRef ID="93971" DB="Orphanet" />
              <XRef ID="93972" DB="Orphanet" />
              <XRef ID="93973" DB="Orphanet" />
              <XRef ID="93974" DB="Orphanet" />
              <XRef ID="93975" DB="Orphanet" />
              <XRef ID="C4759781" DB="MedGen" />
              <XRef ID="MONDO:0010663" DB="MONDO" />
              <XRef Type="MIM" ID="309580" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7356943" SubmissionDate="2023-06-26" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="SUB13573910" submittedAssembly="GRCh37" title="SUB13573910" />
        <ClinVarAccession Accession="SCV003935204" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Department of Rehabilitation, Anhui Provincial Children's Hospital" OrgID="509153" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>DNBSEQ-T7</NamePlatform>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <Description>Whole-exome sequencing (WES) was performed on the proband’s genomic DNA extracted from peripheral blood leukocytes using xGen Exome Research Panel version 2.0 (IDT, IA, United States) and paired-end sequencing (2×150 bp) on DNBSEQ-T7(MGI, China) with not less than 99% regions covered at least 10×. Raw sequence readouts were processed by fastp. Paired-end sequence reads were aligned to the human GRCh37/hg19 genome with Burrows–Wheeler Aligner (BWA). Initial mapping process and variant site identification were conducted using GATK. Annotations were retrieved from the database-based online system independently developed by Chigene (Beijing, China), including allele frequency in the Single Nucleotide Polymorphism database (dbSNP), 1000 Genomes Project, Exome Aggregation Consortium (ExAC), Genome Aggregation Database (gnomAD), ESP, and Chigene in-house MAFs database; positions and associated clinical phenotypes based on UCSC, RefGene, GENCODE, and ENSEMBL transcripts; LOVD, SWISS, Clinvitae, HGMD, OMIM, and ClinVar databases; and functional and conservational predictions for the amino-acid changes according to software packages (Provean, SIFT, PolyPhen2, MutationTaster, M-CAP, REVEL, and CADD; MaxEntScan, dbscSNV, and GTAG; GERP, phyloP, and phastCons). Variant filtering was done according to rare variants with minor allele frequency (MAF) of&lt;1% and biological impact, gene features and disease mechanism, recessive/dominant/de novo pattern of inheritance and segregation analysis, phenotypic relevance through human phenotype ontology (HPO) terms, and scientific literature. Subsequently, pathogenic or likely pathogenic variants we reevaluated according to the American College of Medical Genetics (ACMG) practice guidelines.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATRX">
              <Name>ATRX chromatin remodeler</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000489.6:exon 6</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000489.6:c.399_400dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="309580" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13573910</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7356943" TraitType="Disease" MappingType="XRef" MappingValue="309580" MappingRef="OMIM">
        <MedGen CUI="C4759781" Name="Intellectual disability-hypotonic facies syndrome, X-linked, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

